Veracyte Inc. (VCYT)
NASDAQ · Healthcare
Veracyte Inc. Shareholder Equity 2011–2025
Veracyte Inc. annual shareholder equity history from 2012 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Veracyte Inc. shareholder equity as of December 31, 2025: 1.31B, a 11.36% increase year-over-year.
- Veracyte Inc. shareholder equity for 2025 were 1.31B, a 11.36% increase from 2024.
- Veracyte Inc. shareholder equity for 2024 were 1.18B, a 12.63% increase from 2023.
- Veracyte Inc. shareholder equity for 2023 were 1.04B, a 2.89% decrease from 2022.
- Veracyte Inc. shareholder equity for 2022 were 1.08B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Veracyte Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,310 |
| 2024 | $1,176 |
| 2023 | $1,044 |
| 2022 | $1,075 |
| 2021 | $1,097 |
| 2020 | $421 |
| 2019 | $239 |
| 2018 | $80 |
| 2017 | $37 |
| 2016 | $60 |
| 2015 | $51 |
| 2014 | $41 |
| 2013 | $56 |
| 2012 | $-58 |
Veracyte Inc. Shareholder Equity — FAQ
Veracyte Inc. (VCYT) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VCYT's shareholder equity history?
The chart and table above show Veracyte Inc.'s shareholder equity by year and by quarter, including the growth rate.